National Association of Attorneys General

National Association of Attorneys General National Association of Attorneys General

2017 Presidential Initiative Summit: New York City

2017 Presidential Initiative Summit: Evolving Changes in the American Healthcare Marketplace

Thursday, April 27

The rising cost of prescription drugs is a major concern for health care policymakers — leading many to consider whether we are receiving commensurate value. This panel will provide an overview of the market for prescription drugs, describe the roles of players comprising the pharmaceutical supply chain, and explore the factors that affect drug costs. Panelists will present the perspectives of various market participants, including pharmaceutical manufacturers, private payers, retail pharmacies, pharmacy benefit managers, prescribers, and patients

Moderator:
Len Nichols, Director, Center for Health Policy Research and Ethics (CHPRE) and Professor for Health Policy, George Mason University

Panelists:
Kirsten Axelsen, Member, Vice President for Strategy, Pfizer Essential Health
Peter B. Bach, MD, MAAP, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
Kristin BassSenior Vice President of Policy and Federal Affairs, Pharmaceutical Care Management Association (PCMA)
Leanne Gassaway, Senior Vice President, State Affairs, America's Health Insurance Plans (AHIP)
Thomas Moriarty, Executive Vice President, Chief Health Strategy Officer and General Counsel, CVS Health

Innovations in the use of data and technology in health care hold great potential to reduce costs, increase patient access, and improve the quality of care. Such innovations, however, have legal and policy implications that policymakers continue to address. This roundtable will feature opening remarks on recent developments in health care information technology, followed by presentations from three distinguished experts on the following topics:

· All-Payer Claims Databases
· Electronic Health
· Records Telemedicine

Moderator:
Daniel Barchi, Chief Information Officer, New York-Presbyterian Hospital


Panelists:
Janet Marchibroda, Director of Health Innovation Initiative and Executive Director of CEO Council on Health and Innovation, Bipartisan Policy Center
David Newman, PhD, JD, Executive Director, Health Care Cost Institute
Latoya Thomas, Director, State Policy Resource Center, American Telemedicine Association

Many state policymakers have heard from consumers struggling to afford prescription drugs. In addition, pharmaceutical expenditures — for employee health plans, Medicaid, and other programs — have strained state budgets. As a result, states are considering a range of legislative responses and other policy options to address the fiscal impact of rising prescription drug costs. This panel will summarize such proposals and discuss their relative merits and drawbacks.

Moderator:
Len Nichols, Director, Center for Health Policy Research and Ethics (CHPRE) and Professor for Health Policy, George Mason University

Panelists:
Robert Clark, Sepcial Counsel, Connecticut Attorney General's Office
Chip Davis, President and CEO, Association for Accessible Medicines
Trish Riley, Executive Director, National Academy for State Health Policy
Matt SaloExecutive Director, Association of Medicaid Directors
Kipp Snider, Vice President, State Advocacy, The Pharmaceutical Research and Manufacturers of America (PhRMA)

Although the Affordable Care Act (ACA) remains the law of the land, some observers continue to doubt the long-term stability of the individual insurance markets. Others believe that the ACA is working, but advocate changes to make plans more affordable. In the current political climate, can measures be taken to shore up the ACA exchanges? Regarding Medicaid, what does the future hold for expansion and the recent proposals to allow states more flexibility? Are there promising health care reforms underway that deserve more attention from policymakers? This panel will consider these questions as it engages in a broad discussion regarding the future of health care reform.

Moderator:
George Jepsen, NAAG President and Connecticut Attorney General

Panelists:
Sabrina Corlette, Research Professor, Center on Health Insurance Reforms (CHIR), Georgetown University's Health Policy Institute
Katie Mahoney, Executive Director, Health Policy, U.S. Chamber of Commerce
Thomas MillerResident Fellow, American Enterprise Institute
Marilyn Tavenner, President and CEO, America's Health Insurance Plans (AHIP)

Friday, April 28

States and consumers benefit from lower costs and better quality when health care markets are competitive. Which state policies undermine such competition? What innovative measures might states consider to encourage competition? This panel will address those questions through discussion of various state laws and policies that affect competition in health care, including certificates of public advantage, certificates of need, scope of practice limitations, corporate practice restrictions, and network adequacy requirements.

Moderator:
Thomas Miller, Resident Fellow, American Enterprise Institute 

Panelists:
Wes Cleveland, Senior Attorney, Advocacy Resource Center, American Medical Association (AMA)
Leemore Dafny, MBA Class of 1960 Professor of Business Administration, Harvard Business School
Tara KoslovActing Director, Office of Policy Planning, Federal Trade Commission
Karen Tseng, Chief, Health Care Division, Massachusetts Attorney General's Office

Keynote Speaker

David CordaniPresident and CEO, Cigna Corporation

Health care insurance and provider markets are becoming increasingly consolidated. This panel will explore the economic, regulatory, and other drivers that have led many market participants to increase their scale and market share as well as the potential ramifications of consolidation for patients and consumers. Panelists will also discuss whether and how states may choose to address consolidation through antitrust enforcement and other policies.

Moderator:
Abbe Gluck, Professor of Law and Faculty Director of the Solomon Center for Health Law and Policy, Yale Law School

Panelists:
Henry Allen, Senior Attorney, American Medical Association (AMA)
Leemore DafnyMBA Class of 1960 Professor of Business Administration, Harvard Business School
Mindy Reid HattonSenior Vice President and General Counsel, American Hospital Association (AHA)
Robert F. Leibenluft, Partner, Hogan Lovells

Who's My AG?

Find the attorney general who represents you.

Meetings & Trainings

Stay informed of NAAG meetings and the NAGTRI trainings we offer.

AG Spotlight

Douglas S. Chin, Hawaii Attorney General

Douglas S. Chin is the attorney general of Hawaii.